This application represents the third competitive renewal for our T32 program Training in HIV Pathogenesis. The program supports 6 predoctoral and 3 postdoctoral trainees per year. The program is based at the Perelman School of Medicine at the University of Pennsylvania, the University of Pennsylvania School of Dental Medicine and the Wistar Institute, which occupy a single, contiguous campus in Philadelphia. Together, these institutions have one of the largest HIV/AIDS research programs in the country, with a funding base of >$40 million as determined by the NIH Office of AIDS Research. Closely associated with our training program is our Center for AIDS Research (CFAR) which was renewed in 2014 (i.e. $2.25 million annually), thereby supporting numerous programs that benefit our trainees. Among the many individuals who study HIV/AIDS on our campus, a select group of 17 mentors are associated with this T32 program. In our program, we place special emphasis on collaborative science and a commitment to training students and postdoctoral fellows. The cohesive nature of our training program is demonstrated by the fact that fully 16 of the 17 trainers have published papers with other trainers, that 11 of the trainers share jointly funded NIH grants with other trainers (a total of 11 funded grants, not counting the CFAR grant), 23 of our trainees have published with 2 or more trainers, that there are many joint lab meetings, and that our trainers participate in extensive programmatic activities and minority-recruitment efforts. Over the last 10 years the program has supported 40 predoctoral trainees who worked in 19 different laboratories. Currently, one is an Assistant Professor working on HIV, 1 is a staff scientist at NCI, 9 are now doing postdocs at distinguished universities such as Harvard, Penn, Oxford, UCSF, UCSD, and Tufts, 16 are still in training, 1 just graduated and is looking for a postdoc, 3 with MD/PHD backgrounds are continuing clinical training, 2 are biotech business consultants, 2 are staff scientists in industry, 1 is taking time off to raise twins, 1 isan IP attorney and 1 left for health reasons. Over the last 10 years the program has supported 18 postdoctoral trainees who have worked in 12 laboratories. Currently 1 is an Associate Professor working on HIV, 1 is a Research Assistant Professor, 1 is a director at the AERAS Foundation, 1 is a scientist in industry, 1 is a consultant, 6 are still in training, 3 are technical writer/edtors, 1 works in tech transfer, 1 is unknown, 2 are staff scientists. Many of our trainees are stepping into leadership roles--one leads a TB vaccine program at the AERAS Foundation, another is Chief of the Viral Pathogenesis Section in the Laboratory of Viral Diseases at NIAID, a third founded her own laboratory at Duquesne studying infection and neurotoxicity, a fourth founded her own laboratory working on HIV at Eastern University and was recently appointed to Associate Professor, and a fifth just founded her own laboratory at the University of Washington focused on HIV and SIV research. Based on these outcomes we feel we are training young scientists effectively, and so propose to maintain the training program at the present size.

Public Health Relevance

This application is for the third competitive renewal of 'Training in HIV Pathogenesis' NIH T32 AI007632. The program takes advantage of resources of the UPenn community and to date has trained a total of 74 distinguished young scientists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007632-18
Application #
9291571
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Lawrence, Diane M
Project Start
2000-09-01
Project End
2020-08-31
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
18
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hogan, Michael J; Conde-Motter, Angela; Jordan, Andrea P O et al. (2018) Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization. Virology 514:106-117
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Moser, Emily K; Field, Natania S; Oliver, Paula M (2018) Aberrant Th2 inflammation drives dysfunction of alveolar macrophages and susceptibility to bacterial pneumonia. Cell Mol Immunol 15:480-492
Colón, Krystal; Speicher, David W; Smith, Peter et al. (2018) S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk. J Acquir Immune Defic Syndr :
Sherrill-Mix, Scott; McCormick, Kevin; Lauder, Abigail et al. (2018) Allometry and Ecology of the Bilaterian Gut Microbiome. MBio 9:
Maldini, Colby R; Ellis, Gavin I; Riley, James L (2018) CAR T cells for infection, autoimmunity and allotransplantation. Nat Rev Immunol 18:605-616
Tomescu, Costin; Tebas, Pablo; Montaner, Luis J (2017) IFN-? augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation. AIDS 31:613-622
Knox, James J; Buggert, Marcus; Kardava, Lela et al. (2017) T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight 2:
Chehoud, Christel; Stieh, Daniel J; Bailey, Aubrey G et al. (2017) Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors. AIDS 31:895-904
Wetzel, Katherine S; Yi, Yanjie; Elliott, Sarah T C et al. (2017) CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections. J Virol 91:

Showing the most recent 10 out of 104 publications